Advertisement
CLOV vs PGNY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Buy and PGNY is a Buy.
CLOV's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CLOV turned positive on November 09, 2026. Looking at past instances where CLOV's MACD turned positive, the stock continued to rise in 40 of 47 cases over the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 56 cases where CLOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on CLOV as a result. In 60 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
CLOV moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLOV advanced for three days, in 225 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
CLOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLOV's P/B Ratio (6.804) is slightly higher than the industry average of (3.520). P/E Ratio (-120.500) is within average values for comparable stocks, (126.353). CLOV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.970) is also within normal values, averaging (0.569).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating fairly steady price growth. CLOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Momentum Indicator for PGNY turns positive, indicating new upward trend
PGNY saw its Momentum Indicator move above the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In 75 of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for PGNY just turned positive on October 07, 2026. Looking at past instances where PGNY's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.
PGNY moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PGNY crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +1.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where PGNY advanced for three days, in 237 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 160 of 214 cases where PGNY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGNY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
PGNY broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating fairly steady price growth. PGNY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PGNY's P/B Ratio (5.898) is slightly higher than the industry average of (3.520). P/E Ratio (36.292) is within average values for comparable stocks, (126.353). PGNY's Projected Growth (PEG Ratio) (0.090) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. PGNY's P/S Ratio (1.816) is very high in comparison to the industry average of (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PGNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
CLOV | PGNY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 53 | |
PRICE GROWTH RATING 1..100 | 38 | 35 | |
P/E GROWTH RATING 1..100 | 55 | 52 | |
SEASONALITY SCORE 1..100 | 45 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLOV's Valuation (5) in the null industry is significantly better than the same rating for PGNY (76). This means that CLOV’s stock grew significantly faster than PGNY’s over the last 12 months.
CLOV's Profit vs Risk Rating (100) in the null industry is in the same range as PGNY (100). This means that CLOV’s stock grew similarly to PGNY’s over the last 12 months.
PGNY's SMR Rating (53) in the null industry is somewhat better than the same rating for CLOV (92). This means that PGNY’s stock grew somewhat faster than CLOV’s over the last 12 months.
PGNY's Price Growth Rating (35) in the null industry is in the same range as CLOV (38). This means that PGNY’s stock grew similarly to CLOV’s over the last 12 months.
PGNY's P/E Growth Rating (52) in the null industry is in the same range as CLOV (55). This means that PGNY’s stock grew similarly to CLOV’s over the last 12 months.
| CLOV | PGNY | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 72% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 76% | 7 days ago 82% |
| MACD ODDS (%) | 2 days ago 85% | 7 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| Advances ODDS (%) | 2 days ago 82% | 2 days ago 77% |
| Declines ODDS (%) | 10 days ago 85% | 17 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 71% |
| Aroon ODDS (%) | N/A | 2 days ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLOV’s FA Score shows that 1 FA rating(s) are green while PGNY’s FA Score has 0 green FA rating(s).
- CLOV’s FA Score: 1 green, 4 red.
- PGNY’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLOV’s TA Score shows that 6 TA indicator(s) are bullish while PGNY’s TA Score has 6 bullish TA indicator(s).
- CLOV’s TA Score: 6 bullish, 1 bearish.
- PGNY’s TA Score: 6 bullish, 4 bearish.
Price Growth
CLOV (@Managed Health Care) experienced а +5.97% price change this week, while PGNY (@Managed Health Care) price change was +21.26% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +1.93%. For the same industry, the average monthly price growth was +4.07%, and the average quarterly price growth was +16.14%.
Reported Earning Dates
CLOV is expected to report earnings on Mar 04, 2027.
PGNY is expected to report earnings on Mar 01, 2027.
Industries' Descriptions
@Managed Health Care (+1.93% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement
CLOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLOV has been loosely correlated with ALHC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CLOV jumps, then ALHC could also see price increases.
| Ticker / NAME | Correlation To CLOV | 1D Price Change % | ||
|---|---|---|---|---|
| CLOV | 100% | +0.81% | ||
| ALHC - CLOV | 39% Loosely correlated | +0.26% | ||
| OSCR - CLOV | 35% Loosely correlated | -4.06% | ||
| PGNY - CLOV | 23% Poorly correlated | +0.19% | ||
| HUM - CLOV | 6% Poorly correlated | +1.88% | ||
| MOH - CLOV | 4% Poorly correlated | +1.41% | ||
More | ||||
PGNY and
Correlation & Price change
A.I.dvisor indicates that over the last year, PGNY has been loosely correlated with CLSK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PGNY jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To PGNY | 1D Price Change % | ||
|---|---|---|---|---|
| PGNY | 100% | +0.19% | ||
| CLSK - PGNY | 54% Loosely correlated | +5.18% | ||
| COIN - PGNY | 53% Loosely correlated | +3.13% | ||
| RIOT - PGNY | 48% Loosely correlated | +1.11% | ||
| HOOD - PGNY | 39% Loosely correlated | +4.00% | ||
| COMP - PGNY | 36% Loosely correlated | +2.70% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVAZ | 10.46 | 0.77 | +7.96% |
| 2x Avalanche ETF (AVAZ) | |||
| GLV | 5.95 | 0.06 | +1.00% |
| Clough Global Dividend and Income Fund | |||
| RCG | 2.70 | 0.02 | +0.75% |
| RENN Fund | |||
| GNOV | 43.37 | 0.24 | +0.55% |
| FT Vest U.S. Equity Moderate Buffer ETF - November (GNOV) | |||
| PBPH | 31.64 | N/A | N/A |
| Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) | |||